LPL Financial LLC Decreases Stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

LPL Financial LLC reduced its stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 14.2% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 110,201 shares of the company’s stock after selling 18,194 shares during the quarter. LPL Financial LLC owned about 3.06% of SPDR S&P Pharmaceuticals ETF worth $4,827,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. NBC Securities Inc. raised its position in SPDR S&P Pharmaceuticals ETF by 107,050.0% during the 1st quarter. NBC Securities Inc. now owns 2,143 shares of the company’s stock worth $93,000 after buying an additional 2,141 shares during the last quarter. Beacon Pointe Advisors LLC purchased a new position in SPDR S&P Pharmaceuticals ETF during the 4th quarter worth approximately $211,000. Captrust Financial Advisors raised its position in SPDR S&P Pharmaceuticals ETF by 9.4% during the 4th quarter. Captrust Financial Advisors now owns 5,827 shares of the company’s stock worth $251,000 after buying an additional 500 shares during the last quarter. Sigma Planning Corp raised its position in SPDR S&P Pharmaceuticals ETF by 14.5% during the 1st quarter. Sigma Planning Corp now owns 5,894 shares of the company’s stock worth $258,000 after buying an additional 747 shares during the last quarter. Finally, D. E. Shaw & Co. Inc. raised its position in SPDR S&P Pharmaceuticals ETF by 29.0% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 8,437 shares of the company’s stock worth $363,000 after buying an additional 1,899 shares during the last quarter.

SPDR S&P Pharmaceuticals ETF Trading Up 2.3%

XPH opened at $45.64 on Thursday. SPDR S&P Pharmaceuticals ETF has a 12-month low of $35.22 and a 12-month high of $48.76. The firm has a market capitalization of $164.30 million, a PE ratio of 14.28 and a beta of 0.84. The firm has a 50 day moving average of $42.00 and a two-hundred day moving average of $41.95.

About SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.